Very recently, a group of deleterious heterozygous ATP2B2 missense and end-truncating variants were found in 7 patients affected by a variable spectrum of neurological or neurodevelopmental disorders, including dystonia, ataxia, intellectual disability, behavioral symptoms, and seizures [137] (Fig. 2). The gene discussed is ATP2B2; the disease is Ataxia.